Prenosis makes the Sepsis ImmunoScore, an FDA-authorized AI diagnostic that combines biological markers with clinical data to assess sepsis risk in hospitalized patients. The company says the tool is deployed across 11-plus hospitals and integrates directly into hospital electronic medical record systems. TIME named the Sepsis ImmunoScore one of the 200 Best Inventions of 2024. Prenosis was founded by University of Illinois researchers Bobby Reddy and Rashid Bashir.
Builder’s Brief
Prenosis is a healthcare tool on Falcoscan. FDA-authorized AI diagnostic that predicts sepsis risk in critical care. Falcoscan rates Prenosis with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Prenosis is founded in 2014, currently at Series_a stage. Pricing: Paid.
Market position · Healthcare
How Prenosis compares in Healthcare
Prenosis's opportunity score of 84 ranks #51 of 192 live Healthcare tools on Falcoscan, 1.4 points above the category average of 82.6. Its saturation score is 11/100, against a category average of 11. 86 of the 192 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.
The top-rated live Healthcare tools on Falcoscan, other than Prenosis, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.
Is Prenosis still operating?
Yes. Falcoscan's operating checks list Prenosis as active.
Where is Prenosis based?
Prenosis is headquartered in Chicago, United States.
Does Prenosis have an API?
Falcoscan's records show no public API for Prenosis.
Who is Prenosis for?
Prenosis is built for hospitals, health systems, and critical care clinicians.